Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-067007
Filing Date
2014-11-06
Accepted
2014-11-06 16:28:28
Documents
2
Period of Report
2014-11-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1529
2 POA DOCUMENT poa.txt EX-24.3_544218 3058
  Complete submission text file 0001209191-14-067007.txt   5992
Mailing Address C/O SGX PHARMACEUTICALS, INC. 10505 ROSELLE STREET SAN DIEGO CA 92121
Business Address
GREY MICHAEL G (Reporting) CIK: 0001240122 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 141201078

Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations